ES547915A0 - Procedimiento de microencapsular substancias medicamentosas hidrosolubles por separacion de fases - Google Patents

Procedimiento de microencapsular substancias medicamentosas hidrosolubles por separacion de fases

Info

Publication number
ES547915A0
ES547915A0 ES547915A ES547915A ES547915A0 ES 547915 A0 ES547915 A0 ES 547915A0 ES 547915 A ES547915 A ES 547915A ES 547915 A ES547915 A ES 547915A ES 547915 A0 ES547915 A0 ES 547915A0
Authority
ES
Spain
Prior art keywords
microencapsular
procedure
water
phase separation
medicinal substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547915A
Other languages
English (en)
Other versions
ES8701495A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of ES547915A0 publication Critical patent/ES547915A0/es
Publication of ES8701495A1 publication Critical patent/ES8701495A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B01J13/206—Hardening; drying
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]
ES547915A 1984-10-17 1985-10-16 Procedimiento de microencapsular substancias medicamentosas hidrosolubles por separacion de fases Expired ES8701495A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4979/84A CH660302A5 (fr) 1984-10-17 1984-10-17 Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.

Publications (2)

Publication Number Publication Date
ES547915A0 true ES547915A0 (es) 1986-12-16
ES8701495A1 ES8701495A1 (es) 1986-12-16

Family

ID=4285848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547915A Expired ES8701495A1 (es) 1984-10-17 1985-10-16 Procedimiento de microencapsular substancias medicamentosas hidrosolubles por separacion de fases

Country Status (15)

Country Link
US (1) US4673595A (es)
JP (1) JPS6197216A (es)
AT (1) AT392586B (es)
BE (1) BE903463A (es)
CA (1) CA1259567A (es)
CH (1) CH660302A5 (es)
DE (1) DE3536902A1 (es)
DK (1) DK165355C (es)
ES (1) ES8701495A1 (es)
FR (1) FR2571617B1 (es)
GB (1) GB2165517B (es)
IE (1) IE58245B1 (es)
IT (2) IT8505236A1 (es)
NL (1) NL192249C (es)
SE (1) SE462780B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
AU2810189A (en) * 1987-10-30 1989-05-23 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
IL92344A0 (en) * 1989-01-04 1990-07-26 Gist Brocades Nv Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
DE4223169C1 (de) 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
SE512663C2 (sv) 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
US20030180368A1 (en) * 1998-03-14 2003-09-25 Cenes Drug Delivery Limited Production of microparticles
KR100321854B1 (ko) * 1998-12-30 2002-08-28 동국제약 주식회사 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법
US6833191B2 (en) * 2001-11-20 2004-12-21 Encap Technologies, Llc Microencapsulated particles and process for manufacturing same
KR100722607B1 (ko) 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
JP2016527308A (ja) 2013-08-06 2016-09-08 ドン クック ファーマシューティカル カンパニー リミテッド エンテカビル微小球及びこれを含む非経口投与用医薬組成物
AU2018341389A1 (en) 2017-09-26 2020-04-23 Nanomi B.V. Method for preparing micro-particles by double emulsion technique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173878A (en) * 1960-02-26 1965-03-16 Ibm Process of making microcapsules
JPS5134879A (en) * 1974-09-19 1976-03-24 Eisai Co Ltd Bishochukuryushinoseizoho
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
CH649217A5 (de) * 1977-08-25 1985-05-15 Sandoz Ag Bromocriptin enthaltende mikrokapseln.
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides

Also Published As

Publication number Publication date
CH660302A5 (fr) 1987-04-15
JPS6197216A (ja) 1986-05-15
IE58245B1 (en) 1993-08-11
BE903463A (fr) 1986-02-17
NL8502787A (nl) 1986-05-16
AT392586B (de) 1991-04-25
DK165355B (da) 1992-11-16
SE462780B (sv) 1990-09-03
FR2571617B1 (fr) 1988-08-19
DK165355C (da) 1993-04-05
DE3536902C2 (es) 1991-08-01
CA1259567A (en) 1989-09-19
DK474585A (da) 1986-04-18
DK474585D0 (da) 1985-10-16
SE8504835D0 (sv) 1985-10-16
US4673595A (en) 1987-06-16
IT1187226B (it) 1987-12-16
NL192249B (nl) 1996-12-02
NL192249C (nl) 1997-04-03
SE8504835L (sv) 1986-04-18
GB2165517B (en) 1988-08-10
DE3536902A1 (de) 1986-04-17
IE852459L (en) 1986-04-17
GB2165517A (en) 1986-04-16
IT8505236A1 (it) 1987-04-15
ATA301185A (de) 1990-10-15
FR2571617A1 (fr) 1986-04-18
IT8505236A0 (it) 1985-10-15
ES8701495A1 (es) 1986-12-16
GB8525398D0 (en) 1985-11-20

Similar Documents

Publication Publication Date Title
ES540372A0 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
DK68392D0 (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
DK546886D0 (da) Farmaceutisk praeparat
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK481585A (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
ES547915A0 (es) Procedimiento de microencapsular substancias medicamentosas hidrosolubles por separacion de fases
NO855215L (no) Tilberedelse for retardert teofyllin-utskillelse.
MX3886A (es) Procedimiento para la preparacion de compuestos azoicos hidrosolubles
DK109887A (da) Farmaceutisk praeparat indeholdende antistoffer
DK57086D0 (da) Press foer fasseparering
DK437686D0 (da) Anti-rheumatisk farmaceutisk praeparat
BR8501001A (pt) Medicao de entalpia para substancia de duas fases
DK314283A (da) Farmaceutiske praeparater
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
PT83357B (fr) Procede de preparation de d-ribose
ES551777A0 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
DK80685A (da) Farmaceutisk praeparat til spinalanalgesi
ES539659A0 (es) Procedimiento de preparacion de &-aspartil peptidos
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
RO92109A2 (ro) Procedeu de preparare azodicarboxamidei
ES549685A0 (es) Procedimiento de preparacion de 1-naftiltioamidas
ES529621A0 (es) Procedimiento de preparacion de 1-aril-2-(4-heteroaroilpiperazin-1-il) etanonas
DK68688D0 (da) Fremgangmsaade til adskillelse af stoebeemne
SE8305361D0 (sv) New substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041002